Topical relief of musculoskeletal pain and inflammation associated with soft tissue injuries (eg, bursitis, tendinitis) and trauma-induced injuries (eg, acute strains, sprains, and bruises)
Inhibition of prostaglandin synthesis may affect pregnancy and/or embryonic/fetal development. Some epidemiological study data indicate that the use of prostaglandin synthase inhibitors during early pregnancy increases the risk of miscarriage and congenital heart defects. Animal studies have confirmed that the use of prostaglandin synthase inhibitors leads to an increased rate of pre- and post-implantation embryonic loss and embryonic/fetal mortality. Furthermore, some animal studies have reported an increased incidence of embryonic malformations (including cardiovascular malformations) when prostaglandin synthase inhibitors were used during the organogenesis period. 【文字內容由仿單翻譯而來】